FDA Clears AI Sepsis Monitor, But the Data Trail Doesn't End at Discharge

Frequently Asked

What does FDA 510(k) clearance not cover for AI medical devices?

510(k) clearance certifies that a device is substantially equivalent to a legally marketed predicate — it validates clinical function, not data governance. It does not require the manufacturer to disclose how monitoring data is stored, shared with third parties, or used after discharge. Hospitals bear responsibility for negotiating those terms in vendor contracts.

Why do critics compare AI health tools to consumer apps like Pokemon GO?

The comparison targets the aggregation model: a useful consumer product collects granular data at scale, then that data becomes the real asset — licensed, sold, or repurposed beyond the original use case. Critics argue continuous clinical monitoring tools follow the same structural logic, especially when the business model depends on data that accumulates over years of hospital deployment.

What should a hospital procurement team ask before deploying a cleared AI monitoring device?

Ask for explicit contractual terms on three points: who owns the de-identified or re-identifiable monitoring data, whether the vendor can use it for model retraining or secondary licensing, and what happens to stored data if the contract ends. FDA clearance does not constrain any of these — the contract does.

Continue reading